×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast ...
PR Newswire
PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies,...
2 weeks ago
Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement
WilmerHale
WilmerHale advised Karyopharm, a commercial-stage pharmaceutical company pioneering novel cancer therapies, in its recently announced series...
1 week ago
Karyopharm to Present at 42nd Annual J.P. Morgan Healthcare Conference
Karyopharm
Since its founding, Karyopharm has been an industry leader in oral Selective Inhibitor of Nuclear Export (SINE) compound technology, which was...
4 months ago
Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript
The Motley Fool
Karyopharm Therapeutics (KPTI -2.68%) Q1 2024 Earnings Call May 08, 2024, 8:00 a.m. ET. Contents: Prepared Remarks; Questions and Answers...
2 weeks ago
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2024 Earnings Call Transcript
Yahoo Finance
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2024 Earnings Call Transcript May 8, 2024 Karyopharm Therapeutics Inc. isn't one of the 30...
2 weeks ago
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of ...
PR Newswire
"As we follow the endometrial cancer patients whose tumors are TP53wt and evaluate the long-term benefit, our confidence for selinexor to...
4 weeks ago
Karyopharm Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Yahoo Finance
Karyopharm Therapeutics ( NASDAQ:KPTI ) First Quarter 2024 Results Key Financial Results Revenue: US$33.1m (down 14...
1 week ago
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is a commercial-stage pharmaceutical company pioneering novel cancer therapies. Since its founding,...
1 month ago
Market Sentiment Around Loss-Making Karyopharm Therapeutics Inc. (NASDAQ:KPTI)
Yahoo
We feel now is a pretty good time to analyse Karyopharm Therapeutics Inc.'s ( NASDAQ:KPTI ) business as it appears the...
1 day ago
Karyopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference
PR Newswire
PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies,...
2 weeks ago